Sorafenib as Monotherapy or in Association With Cytarabine and Clofarabine for the Treatment of Relapsed/Refractory FLT3 ITD-Positive Advanced Acute Myeloid Leukemia

Clinical Lymphoma, Myeloma and Leukemia - United States
doi 10.1016/j.clml.2013.08.005